PubMed / Veterinary Dermatology · Research Explained · August 1, 2026
A Retrospective Case Series Reporting the Clinical Efficacy and Adverse Events of Oclacitinib Administration for Skin Disease in 238 Cats
A retrospective series of 238 cats receiving off-label oclacitinib found clinical benefit in many patients and documented adverse events including neutropenia, gastrointestinal signs, lethargy, infection, and laboratory changes.